united states food and drug administration Archives

First Drug That Protects Against Chemo-Induced Myelosuppression

02/15/2021 Health News

A novel drug that offers multilineage protection from chemotherapy-induced myelosuppression has been approved by the US Food and Drug Administration. […]

» Read more

adverse effects, bleeding, Bone Marrow, bone marrow suppression, cancer (lung), chemotherapy, clinical research, clinical studies, clinical trials, Fatigue:, FDA, headache, hematology, hemorrhage, Immunotherapy, interstitial lung disease, Lung Cancer, lung carcinoma, Myelosuppression, neutropenia, side effects, small-cell lung cancer, u.s. food and drug administration, united states food and drug administration

Serious, ‘Unexpected’ Adverse Events From Nasal Esketamine

First Drug That Protects Against Chemo-Induced Myelosuppression